GENERIC NAME OF MEDICINAL PRODUCT:

A. Lignocaine Hydrochloride & Adrenaline Bitartrate Injection IP 2%w/v +(1:80,000)
B. Lignocaine Hydrochloride & Adrenaline Bitartrate Injection IP 2%w/v +(1:200,000)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A. Lignocaine Hydrochloride & Adrenaline Bitartrate Injection IP 2%w/v +(1:80,000)
Each ml contains:
Lignocaine Hydrochloride IP……………..21.33mg
Equivalent to anhydrous
Lignocaine Hydrochloride…………………20mg
Adrenaline Bitartrate IP……………………0.0225mg
(Equivalent to Adrenaline…………………0.0125mg)
Sodium Chloride IP…………………………..6.0mg
Sodium Metabisulphite IP…………………0.5mg
Methylparaben IP (as preservative)…..1.0mg
Water for Injections IP……………………….q.s

B. Lignocaine Hydrochloride & Adrenaline Bitartrate Injection IP 2% w/v +(1:200,000)
Each ml contains:
Lignocaine Hydrochloride IP……………..21.33mg
Equivalent to anhydrous
Lignocaine Hydrochloride…………………20mg
Adrenaline Bitartrate IP……………………0.009mg
(Equivalent to Adrenaline…………………0.005mg)
Sodium Chloride IP…………………………..6.5mg
Potassium Metabisulfite BP…………………1.2mg
Methylparaben IP (as preservative)…..1.0mg
Water for Injections IP……………………….q.s


THERAPEUTIC INDICATION:

ADRENALINE+LIGNOCAINE is used to reduce pain and discomfort caused by invasive medical procedures such as surgery, needle punctures or insertion of a breathing tube or catheter. It is also used to reduce the discomfort of contractions during labour.

DIRECTION OF USE:

For Intramuscular use only.
Refer enclosed leaflet for full prescribing information.

CAUTION AND SCHEDULE:

CAUTION: Do not use in case any foreign particulate matter is observed inside the vial.
Not to be given Intravenously.
Not more than 10 withdrawals.
To be administered after a test dose with adequate precaution to cope with any adverse reactions.
KEEP OUT OF REACH AND SIGHT OF CHILDREN.
FLIP-OFF SEAL IS PROVIDED FOR TAMPER EVIDENCE.
SCHEDULE: SCHEDULE 'H PRESCRIPTION DRUG-CAUTION Not to be sold by retail without the prescription of a Registered Medical Practitioner.

STORAGE AND DOSAGE:

STORAGE: Store below 25℃. Store in a cool, dry and dark place. Protect from light.
DOSAGE: As directed by the Physician.

Lignocaine Hydrochloride & Adrenaline Bitartrate Injection IP 2% w/v + (1:200,000) Technical Specification:

Product Name:Lignocaine Hydrochloride & Adrenaline Bitartrate Injection IP
Brand Name:Generic
Strength:2% w/v + (1:200,000), 2%w/v +(1:80,000)
Dosage Form:Liquid Injection
Packing:30ml Multiple Dose Vial
Route of Administration:For I.M. use only
Pack Insert/Leaflet:PIL (Patient Information Leaflet)
Documents:COA, MOA, Product Permission, Stability Studies, GMP
Therapeutic use:Local Anesthetic
Indication: Lignocaine & Adrenaline Injection is used to reduce pain and discomfort caused by invasive medical procedures such as surgery, needle punctures or insertion of a breathing tube or catheter. It is also used to reduce the discomfort of contractions during labour.
Storage:Store below 25℃. Store in a cool, dry and dark place. Protect from light.

GENERIC NAME OF MEDICINAL PRODUCT:

  • Lignocaine Hydrochloride & Adrenaline Bitartrate Injection IP 2%w/v +(1:200,000)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Lignocaine Hydrochloride & Adrenaline Bitartrate Injection IP 2%w/v +(1:200,000)
    Each ml contains:
    Lignocaine Hydrochloride IP……………..21.33mg
    Equivalent to anhydrous
    Lignocaine Hydrochloride…………………20mg
    Adrenaline Bitartrate IP……………………0.009mg
    (Equivalent to Adrenaline…………………0.005mg)
    Sodium Chloride IP…………………………..6.5mg
    Sodium Metabisulphite IP…………………1.2mg
    Methylparaben IP (as preservative)…..1.0mg
    Water for Injections IP……………………….q.s

THERAPEUTIC INDICATION:

ADRENALINE+LIGNOCAINE is used to reduce pain and discomfort caused by invasive medical procedures such as surgery, needle punctures or insertion of a breathing tube or catheter. It is also used to reduce the discomfort of contractions during labour.

DIRECTION OF USE:

For Intramuscular use only.
Refer enclosed leaflet for full prescribing information.

CAUTION AND SCHEDULE:

CAUTION: Do not use in case any foreign particulate matter is observed inside the vial.
Not to be given Intravenously.
Not more than 10 withdrawals.
To be administered after a test dose with adequate precaution to cope with any adverse reactions.
KEEP OUT OF REACH AND SIGHT OF CHILDREN.
FLIP-OFF SEAL IS PROVIDED FOR TAMPER EVIDENCE.

SCHEDULE: SCHEDULE ‘H PRESCRIPTION DRUG-CAUTION Not to be sold by retail without the prescription of a Registered Medical Practitioner.

STORAGE AND DOSAGE:

STORAGE:  Store below 25℃. Store in a cool, dry and dark place. Protect from light.

DOSAGE: As directed by the Physician.